Join Aberdeen's leading business angel group Find carefully-selected investments
Send us your funding proposals
The investment opportunities below are some of those Aurora has received recently.
This company has developed leading anti-infective therapies, one of which has achieved completely successful Phase 1 (safety) and Phase 2a (dosing) clinical trial results. The company is currently completing a bridging funding round of £800k while an institution investment round is secured from VCs and/or licensors. Read more »
Air-Fi Intelligent Airspace is a web network for global travelers connecting and branding cities through culture, art, style, fashion and design.
This company creates attractive and engaging computer games with world-wide appeal. Its business model is geared at enabling a small independent developer to produce games at significantly lower cost, to retain the IP and build customer loyalty. Read more »
This young award-winning company has already started selling its herbal teas both online and via three major UK supermarket chains. The niche market that it addresses is not served specifically nor, in the company’s view, with products that actually taste as good as its do. Read more »
This company has developed an excellent, non-invasive test for cancer of a major organ in the human body. Recent studies show that the test is not only highly sensitive but also very specific. The underlying technology has been proven to be successful in diagnosis of cancers affecting other organs of the body. Read more »
A business incubator with a 22-year track record helping start-up and young businesses now plans to enable Scottish business angels and groups such as Aurora Private Equity to get in at the start helping promising prospects. A new business angel group will select the best prospects coming to the incubator. Read more »
Based in Aberdeen, Aurora helps companies with great ideas and bright people.
Aurora is open to new members who see the sense in these times of low interest rates and stock market…
Professor Andy Porter of Aberdeen University says anti-fungal drug could deliver “blockbuster” revenues.
Aurora is keen to invest in and support companies ready for funding. Tell us more.